Plantinha do Mato - Glicongoya Review and Ads Breakdown

What Is Plantinha do Mato - Glicongoya

Plantinha do Mato - Glicongoya is presented as a diabetes-related natural health offer centered on a tea, homemade drink, or plant-based recipe. The VSL describes it as a simple preparation that can be made at home, sometimes framed as a “plantinha do mato,” sometimes as a Japanese recipe, and in the ad transcript as a three-ingredient drink that “anyone has at home.”

The format is important. The transcript does not read like a standard ecommerce page for a bottled supplement. It reads like a video sales letter designed to keep viewers watching until a later reveal. The main call to action is not “buy this bottle now.” It is to continue watching the video or click the button to see the step-by-step recipe. The copy repeatedly says the viewer can learn the process in about three minutes and use it “tonight.”

The product name supplied for this analysis is Plantinha do Mato - Glicongoya, but the transcript itself mostly discusses the method through broader phrases: wild plant, tea, simple drink, Japanese recipe, and three steps. The ad also introduces the phrase “insulina do Mediterrâneo”, or “Mediterranean insulin,” while the main VSL leans heavily on Japan, especially Nagano, Okinawa, and Nakagawa.

From a positioning standpoint, Glicongoya sits in the blood sugar support niche, specifically targeting people with diabetes concerns. The emotional focus is type 2 diabetes. The VSL mentions A1c, glucose readings, metformin, insulin, Ozempic, Glifage, neuropathy, frequent urination, blurred vision, and wounds that do not heal. However, the presentation goes beyond ordinary supplement positioning by implying that standard diabetes advice misses the real cause.

According to the VSL, the real problem is not sugar, aging, genetics, or lack of exercise. The presentation claims the true culprit is a hidden “diabetic worm” or “sugar parasite” affecting the pancreas. This is the offer’s unique mechanism. It is also one of the biggest claims in the entire transcript and should be treated as a claim made by the sales presentation, not as established medical fact.

The Problem It Targets

The VSL targets the emotional and practical burden of diabetes. It speaks to people who feel exhausted by glucose monitoring, dietary restriction, medication costs, and fear of complications. The speakers describe diabetes as a “plague,” a “prison,” and a condition that steals normal life.

The main pain point is uncontrolled blood sugar. The transcript includes glucose numbers like 480, 325 after meals, 142 fasting, 112, 97, 95, and under 90. These numbers are used as emotional anchors. High numbers create fear. Lower numbers create hope. The viewer is invited to imagine moving from dangerous glucose spikes to stable readings without feeling restricted.

The VSL also emphasizes complications. It mentions fear of going blind, losing a leg, developing neuropathy, having wounds that do not heal, and even dying from diabetes-related complications. One speaker says diabetes almost left him blind and without his right leg. Another story centers on the death of the narrator’s daughter, Clara, after years of diabetes struggles. Carlos, the husband, then develops worsening symptoms and a foot ulcer.

This is not casual wellness copy. It is high-stakes fear-based direct response. The presentation wants the viewer to feel that doing nothing is dangerous and that conventional care may not be enough.

The secondary pain is loss of freedom. The speakers talk about being told to eat salad, walk, avoid carbohydrates, avoid sweets, avoid beer, and give up the foods that gave life pleasure. The ad transcript says the person could not eat banana, bread, cake, or beer. The main VSL says the person now goes out with grandchildren, eats “besteira,” drinks beer on game day, and no longer feels guilt.

A third pain is financial pressure. One speaker says he left half a minimum wage at pharmacies buying medication. The ad says the person spent more than 500 reais per month on Glifage and insulin. This creates a sharp contrast with the claimed cost of the recipe: less than 10 reais.

Finally, the VSL targets shame. One speaker says he always tried to keep the disease secret. The copy understands that diabetes is not only a clinical issue for the target audience. It is framed as a private embarrassment, a daily frustration, and a threat to identity.

How Plantinha do Mato - Glicongoya Works

According to the presentation, Plantinha do Mato - Glicongoya works by helping the body eliminate excess sugar through urine. The VSL repeatedly uses language like “drenar todo o açúcar do meu sangue” and “eliminar o parasita açucarado pelo xixi.” In English, the claim is that the tea drains sugar from the blood and removes the alleged sugar parasite through urination.

The most important point: this is the manufacturer or presenter’s claim. The transcript does not provide clinical proof that a tea can remove diabetes, reverse type 2 diabetes, replace medication, or eliminate a pancreatic parasite. It states these ideas as part of the sales narrative.

The alleged mechanism has three pieces. First, the VSL says the usual explanations for diabetes are wrong or incomplete. The script says the problem is not mainly genetics, sugar, or age. Second, it introduces the villain: a hidden parasite that allegedly attacks or sucks sugar from the pancreas and disrupts insulin control. Third, it claims the drink removes this parasite and excess sugar through urine, allowing glucose to normalize.

This mechanism is designed to create a breakthrough feeling. Many diabetes offers talk about insulin sensitivity, metabolism, inflammation, weight, or carbohydrate handling. This VSL instead uses a more dramatic claim: viewers have been treating the wrong problem because the true cause is hidden inside the body. That makes the solution feel exclusive and urgent.

The presentation also claims rapid timelines. One opening speaker says it took 7 days for the tea to drain sugar from the blood. Another says glucose dropped to 112 in five days and stayed below 90 by the tenth day. The ad transcript says glucose went to 110 on the sixth day, 95 on the eighth, and 97 after nine days without metformin. Speaker C says numbers stopped oscillating after 3 days.

Those timelines are central to the pitch, but they are anecdotal within the transcript. They are not presented with lab reports, physician notes, controlled trial data, or full context about diet, medication, diagnosis, or measurement conditions.

Key Ingredients and Components

The transcript does not disclose a confirmed Glicongoya ingredient list. That is one of the most important findings in this review.

The VSL mentions a wild plant, a tea, a simple homemade drink, and a three-step method. The ad transcript says it is a tea with three ingredients that anyone has at home and says the preparation takes about three minutes. However, the actual ingredients are not named in the supplied transcript.

Because the transcript does not identify the plant or the full formula, it would be inaccurate to claim that Glicongoya contains cinnamon, berberine, gymnema, bitter melon, banaba, chromium, or any other common blood sugar ingredient. Those nutrients and botanicals often appear in the broader blood sugar supplement category, but they are not confirmed here.

In the diabetes support category, typical products may use ingredients associated with glucose metabolism, insulin sensitivity, carbohydrate digestion, or antioxidant support. Examples in the broader market can include cinnamon, chromium, alpha-lipoic acid, berberine, gymnema sylvestre, bitter melon, or banaba leaf. But again, those are category examples only. The supplied transcript does not say that Plantinha do Mato - Glicongoya contains any of them.

The only disclosed components are conceptual rather than formula-specific: a plant, a tea, a recipe, three steps, and an alleged method for removing sugar through urine. For a buyer or researcher, that is a major transparency gap. A credible supplement or health product review normally needs the exact ingredient names, dosages, serving instructions, contraindications, and safety warnings. This transcript provides none of those details.

The VSL Hook and Story

The main hook is extreme: “You only have diabetes if you want to after using this wild plant.” That line is designed to shock. It implies that diabetes becomes optional once the viewer knows the plant method. From an editorial perspective, this is an aggressive health claim and should not be taken as medical fact.

The second hook is the medication escape story. The speaker says a doctor predicted lifelong injections, but the speaker threw away insulin and metformin. Another speaker says he threw Glifage into the fire and later got rid of insulin. The ad uses similar lines about glucose falling without metformin and later stopping insulin.

Then the story widens. The VSL introduces Japan as the place where the hidden truth was discovered. It claims regions like Nagano, Okinawa, and Nakagawa have extremely low diabetes rates, with less than 0.5% of the population suffering from type 2 diabetes. The script says people there eat rice, sake, noodles, fatty meats, sweets, pizza, bread, and other high-carbohydrate foods while maintaining healthy glucose levels.

The authority character is Hannah Yano, also rendered in the transcript as Hanna Ayano or Hannah Anno. She is presented as a 53-year-old doctor specialized in nutrition and health, trained at Johns Hopkins in Baltimore, with 28 years of medical experience. Her backstory includes being born in Nagano, moving to Brazil at age 13, losing her daughter Clara to diabetes complications, and trying to save her husband Carlos.

This is a classic direct-response origin story. The doctor is not merely an expert. She has personal loss. She has a spouse in danger. She has a reason to reject conventional answers. She returns to Japan, notices something strange, and seeks a natural solution.

The emotional center of the VSL is the death of Clara. The story says Clara followed standard diabetes measures: glucose monitoring, strict diet, exercise, Ozempic, metformin, and insulin. According to the presentation, her glucose still became unpredictable, and she died on June 4, 2021 after a sudden cardiac arrest. This tragedy becomes the narrator’s motivation to investigate diabetes more deeply.

Carlos then becomes the second emotional driver. After Clara’s death, his health declines. He develops neuropathy, injures his foot, and gets an ulcer. The narrator fears amputation. On November 23, 2021, she decides to return to Japan. This creates the turning point that leads into the alleged discovery.

The story is built to make the viewer feel that the solution was not invented casually. It was discovered through grief, urgency, family, and medical frustration.

Ads Breakdown

The supplied ad transcript uses the same core ideas as the main VSL but compresses them into faster, more social-media-friendly hooks.

The first ad angle is urinary sugar elimination. It opens by asking what age the viewer discovered that excess sugar can be eliminated through urine without medicine. This is a curiosity hook. It implies the viewer has missed a simple biological shortcut.

The second angle is fast glucose proof. The ad says, “My glicemia went to 97, without metformin, after 9 days.” That combines a specific number, a medication-free claim, and a short timeline. Specificity makes the claim feel more concrete, even though the transcript does not provide documentation.

The third angle is near-loss and rescue. The speaker says she almost lost vision in both eyes, suffered for 12 years, and nearly missed seeing her grandchildren grow up. This angle targets older adults and grandparents who fear losing independence or family moments.

The fourth angle is ordinary-life restoration. The ad says the person now eats pizza, bread, cake, drinks beer with friends, and sees children grow. This is not framed as abstract health improvement. It is framed as permission to live normally again.

The fifth angle is the hidden parasite. The ad claims the problem is not carbohydrates, age, or genetics, but a parasite in the pancreas that is “sequestering” insulin. This is the ad’s breakthrough mechanism. It gives the viewer a reason why previous attempts failed.

The sixth angle is foreign village proof. Interestingly, the ad transcript shifts from Japan to a “communityzinha francesa antiga” and a clinic in Provence, while still referencing Dr. Hannah Yano. It also calls the drink “insulina do Mediterrâneo.” This creates some narrative inconsistency with the main VSL’s Japan/Nagano frame, but the persuasive function is the same: a remote population supposedly eats carbs and avoids diabetes because of a traditional drink.

The seventh angle is censorship urgency. The ad says the video was recorded secretly in the back of a clinic, has been taken down several times, and may not last. This pushes immediate action: click below and watch now.

Overall, the ads are built around speed, fear, simplicity, hidden knowledge, and a short video reveal. The goal is not to explain the product fully in the ad. The goal is to make the viewer feel they must watch the VSL before the opportunity disappears.

Psychological Triggers and Persuasion Tactics

The strongest trigger in the Glicongoya VSL is fear. The transcript repeatedly mentions blindness, amputation, neuropathy, wounds, heart attack, and death. These are real fears for people living with diabetes, but the VSL uses them aggressively to create urgency.

The second trigger is hope after failure. The target viewer has tried diet, walking, medication, increased doses, internet teas, cinnamon, red onion, salad, and restriction. Nothing works, according to the story. Then the plant appears as the one simple thing that finally changes the outcome.

The third trigger is conspiracy. The presentation claims pharmaceutical companies like Simed, EMS, and Medley profit from keeping people dependent. It also names medications such as Ozempic, Metformin, and insulin. According to the VSL, companies hide studies, manipulate media, corrupt politicians, and benefit from patient dependence. These are claims made by the sales script; the transcript does not provide evidence for them.

The fourth trigger is borrowed authority. The VSL references Fantástico, Dr. Drauzio Arella, Johns Hopkins, a Tokyo health conference, Japanese longevity regions, and a doctor named Hannah Yano. These references create an aura of legitimacy, even though the transcript does not provide verifiable citations.

The fifth trigger is social proof. The VSL says more than 20,000 Brazilians tested the method and 88% reversed the condition. The ad says more than 17,000 Brazilians tested it and 92% reversed type 2 within a month. It also mentions church members and family members lowering glucose. The numbers are persuasive, but the transcript does not show the underlying study.

The sixth trigger is scarcity through censorship. The viewer is told the video has been removed 15 times in one week or taken down several times. The implication is that access is fragile. If the viewer leaves, they may lose the chance.

The seventh trigger is low effort. The method is described as lazy, cheap, natural, easy, and quick. It allegedly costs less than 10 reais, takes three minutes to learn, and can be started the same night. Low effort is crucial for a market tired of diets, walks, injections, and restrictions.

Scientific and Authority Signals

The VSL uses many science and authority signals, but most are not substantiated inside the transcript.

The biggest authority figure is Hannah Yano, described as a doctor specialized in nutrition and health, trained at Johns Hopkins in 1996, and practicing for 28 years. The script says she gives interviews, speaks at events, and dedicated her life to diabetes discoveries. This gives the offer a medical narrator.

The second authority signal is Japan. The VSL leans on Nagano, Okinawa, and Nakagawa as regions with unusual longevity and allegedly very low diabetes rates. According to the presentation, people there eat high-carbohydrate foods but do not develop diabetes at normal rates. This is used as population-level proof for the recipe.

The third signal is media. The VSL says a report by Dr. Drauzio Arella on Fantástico revealed the truth about type 2 diabetes hidden in Japan. It also claims that Globo removed the report because of pharmaceutical sponsorship. Again, these are claims inside the VSL, not verified by the transcript.

The fourth signal is research language. The presentation mentions hidden studies, a doctor’s study, clinical settings, autopsy findings, A1c, fasting glucose, post-meal glucose, neuropathy, and pancreatic damage. This medical vocabulary makes the pitch feel clinical.

But the key limitation is disclosure. The transcript does not provide study titles, journal names, trial protocols, sample criteria, safety data, or ingredient dosages. It does not show lab reports or medical records for the testimonials. It does not document the alleged parasite mechanism.

So the correct editorial reading is this: the VSL contains authority signals, but the transcript does not contain enough evidence to verify the health claims.

What Real Buyers Say

The transcript includes many first-person transformation statements. These are presented as testimonials or personal stories within the sales material.

One opening speaker says, “Joguei fora minha insulina e metformina” and “Minha glicose não passa de 90.” That is a strong medication-discontinuation claim, and anyone hearing it should be cautious. Diabetes medication should not be stopped without medical supervision.

Another speaker says his glucose had reached 480, that he had blurry vision, libido changes, tingling hands and feet, wounds that would not heal, constant urination, and heavy pharmacy spending. He later claims, “Minha glicose caiu para 112 em cinco dias” and says that by the tenth day his glucose no longer passed 90.

Speaker C says the method stopped glucose swings after 3 days and helped with morning weakness, tremors, and blurred vision. This speaker says, “Me senti eu mesmo de novo, sem medo, sem culpa” and “Recuperei minha energia.” The story also includes eating chocolate ice cream with a granddaughter without guilt.

The ad testimonial says the person suffered for 12 years, nearly lost vision, spent over 500 reais per month on Glifage and insulin, and saw glucose fall to 110 on day six and 95 on day eight. The ad also claims the person stopped metformin and later insulin.

These testimonials are emotionally powerful because they are concrete. They include numbers, foods, family scenes, pharmacy costs, and daily symptoms. But they are still testimonials inside a sales transcript. The transcript does not provide independent verification.

The Offer / Pricing / Risk Reversal

The transcript does not disclose a standard price for Plantinha do Mato - Glicongoya. There is no clear checkout price, bottle count, subscription term, shipping fee, or refund policy in the supplied material.

Instead, the offer uses price contrast. The drink is said to cost less than 10 reais to prepare, while medications are framed as expensive. One speaker says he spent half a minimum wage at pharmacies. The ad says more than 500 reais per month went to Glifage and insulin. This creates the impression that the recipe is financially low risk.

The VSL also uses a soft risk reversal: test it for 7 days. One speaker says to test it for seven days and then come back to thank him. That is not the same as a formal guarantee. No money-back promise is provided in the transcript.

The urgency is built around access, not inventory. The viewer is told the video has been taken down multiple times, censored, or removed by Globo. The message is that the viewer should watch now because the information may disappear.

Who This Is For (and Who It Isn't)

Based on the transcript, Plantinha do Mato - Glicongoya is aimed at adults with type 2 diabetes concerns who feel disappointed by medication, frustrated by restrictive diets, and afraid of complications. It is written for people who want a natural, simple, low-cost alternative and who respond strongly to personal stories of regained freedom.

It may especially appeal to viewers who identify with spending too much at pharmacies, feeling ashamed of diabetes, missing normal meals, or fearing blindness and amputation. The VSL speaks directly to those emotions.

It is not for people looking for transparent supplement labeling. The transcript does not reveal the confirmed ingredients. It is not for people who need published clinical evidence before considering a health product. The transcript mentions studies and results but does not provide enough detail to evaluate them.

Most importantly, it is not a substitute for medical care. The VSL includes claims about throwing away insulin, stopping metformin, and no longer needing medications. Those claims are risky if copied without supervision. Anyone with diabetes should speak with a qualified clinician before changing medication, diet, or glucose-management routines.

Frequently Asked Questions

What is Plantinha do Mato - Glicongoya?

Plantinha do Mato - Glicongoya is presented as a natural tea or homemade drink method for blood sugar concerns. The VSL frames it as a simple plant-based recipe connected to Japanese or Mediterranean traditional practices.

Does the transcript reveal the Glicongoya ingredients?

No. The transcript refers to a wild plant, a tea, a simple drink, and three ingredients in the ad, but it does not name the exact ingredients. Any specific ingredient list would go beyond the supplied source.

What does the Glicongoya VSL claim about diabetes?

According to the presentation, the method can help lower glucose, remove excess sugar through urine, and reduce medication dependence. These are claims from the VSL, not independently verified facts in the transcript.

Is the alleged pancreatic parasite proven in the transcript?

No. The alleged pancreatic parasite or sugar parasite is the central mechanism claimed by the presentation, but the transcript does not provide verifiable scientific proof for it.

How much does Plantinha do Mato - Glicongoya cost?

The transcript does not disclose a product purchase price. It claims the homemade drink can be made for less than 10 reais.

What are the main ad hooks used for Glicongoya?

The ads focus on fast glucose drops, eliminating sugar through urine, stopping metformin, avoiding vision loss, a hidden parasite, a short recipe video, and censorship urgency.

Does the VSL provide scientific proof?

It provides scientific-sounding claims and authority references, but not complete scientific proof. No journal citations, clinical trial methods, ingredient dosages, or safety data are included in the supplied transcript.

Who should be cautious about this offer?

Anyone using diabetes medication should be cautious, especially insulin users. The transcript includes medication-stopping stories, but changes to diabetes treatment should only happen with professional medical guidance.

Final Take

Plantinha do Mato - Glicongoya is a forceful diabetes VSL built around a dramatic promise: a cheap, simple plant-based tea can allegedly lower glucose quickly and help remove excess sugar through urine. The offer’s strongest assets are emotional storytelling, vivid pain points, fast-result testimonials, and the unique mechanism of an alleged sugar parasite in the pancreas.

From a direct-response perspective, the VSL is highly engineered. It combines fear, authority, conspiracy, scarcity, social proof, and low-effort transformation. It gives the viewer a villain, a doctor-guide, a hidden discovery, and a future where food, family, and freedom return.

From an editorial research perspective, the weaknesses are just as clear. The transcript does not disclose the confirmed Glicongoya ingredients, does not provide a formal product price, does not show clinical citations, and does not prove the alleged parasite mechanism. The strongest claims are presented as testimonials and sales narration rather than documented medical evidence.

The safest reading is this: Glicongoya is marketed as a natural diabetes-support tea recipe with aggressive claims, but the supplied transcript does not provide enough transparent evidence to validate those claims. Anyone evaluating this offer should separate the emotional appeal from the proof actually shown, and should never stop prescribed diabetes medication based on a VSL.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.